Cargando…
Current and Future Immunotherapy-Based Treatments for Oesophageal Cancers
SIMPLE SUMMARY: Immunotherapy has become a crucial component in the therapeutic options against diseases such as cancer. The development of these treatments to target cancer is built upon the ever-increasing knowledge of the tumour microenvironment for which the alterations in the immune response ar...
Autores principales: | To, Natalie, Evans, Richard P. T., Pearce, Hayden, Kamarajah, Sivesh K., Moss, Paul, Griffiths, Ewen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265112/ https://www.ncbi.nlm.nih.gov/pubmed/35804876 http://dx.doi.org/10.3390/cancers14133104 |
Ejemplares similares
-
The Evolution of Neo-Adjuvant Therapy in the Treatment of Oesophageal and Gastro-Oesophageal Junction Adenocarcinomas
por: Dermanis, Alexander A., et al.
Publicado: (2023) -
Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by radical surgery for locally advanced oesophageal squamous cell carcinoma: meta-analysis
por: Kamarajah, Sivesh K, et al.
Publicado: (2022) -
P22 Are Elderly Patients at Increased Perioperative Morbidity and Mortality from Oesophagectomy for Oesophageal Cancer? A Systematic Mapping Review and Meta-Analysis
por: Gujjuri, Rohan R, et al.
Publicado: (2021) -
Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma
por: Kamarajah, Sivesh K, et al.
Publicado: (2023) -
ASO Author Reflections: Challenges in the Management of Gastroesophageal Junctional Adenocarcinoma
por: Kamarajah, Sivesh K., et al.
Publicado: (2021)